Related Experiment Video
Updated: May 31, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
The Novel Compound SIC-19 Triggers CUL4B-Mediated Ubiquitination and Degradation of SIK2
Yeqiu Zou1, Jiaqi Liu1, Shunpeng Zhu1
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract:
Small-molecule inhibitors represent a novel potential therapeutic for tumors. Our previous work identified SIC-19, a small molecule compound that induces degradation of salt-inducible kinase 2 (SIK2), leading to apoptosis and reduced proliferation in tumor, expecting to be a promising clinical treatment for ovarian cancer. While we initially observed that SIC-19 triggers SIK2 ubiquitination, the underlying mechanism was unknown. Here we elucidate this process by demonstrating that SIC-19 promotes the interaction between SIK2 and the CUL4B-DDB1 E3 ubiquitin ligase. Mass spectrometry discovered several ubiquitin ligases that bind to SIK2. Immunoprecipitation assays revealed that the CUL4B-DDB1 ligase is an interaction partner of SIK2. Through Western blot analysis, we demonstrated that CUL4B is functionally required for SIC-19-induced ubiquitination and SIK2 degradation. The ubiquitination and half-life of SIK2 are directly correlated with the dosage of SIC-19 and the expression of CUL4B. Site-directed mutagenesis and ubiquitination assays further confirmed that lysine 144 (K144) is the critical residue in SIK2 that regulates cancer behavior as cell proliferation and migration by leading to the degradation of SIK2. Our findings define a novel mechanism wherein SIC-19 induces CUL4B-dependent ubiquitination and degradation of SIK2, possesses the potential to act as an inhibitor, and may subsequently be developed as a targeted agent.
Insights
SIC-19, a novel small molecule, targets salt-inducible kinase 2 (SIK2) degradation. This mechanism involves CUL4B-DDB1 ligase, offering potential for ovarian cancer targeted therapy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Small-molecule inhibitors are emerging as potential cancer therapeutics.
- Previous research identified SIC-19 as a compound inducing salt-inducible kinase 2 (SIK2) degradation, showing promise for ovarian cancer treatment.
- The precise mechanism by which SIC-19 induces SIK2 ubiquitination remained unclear.
Purpose of the Study:
- To elucidate the mechanism of SIC-19-induced SIK2 ubiquitination and degradation.
- To identify the E3 ubiquitin ligase complex responsible for SIK2 ubiquitination.
- To determine the role of specific SIK2 residues in this degradation pathway.
Main Methods:
- Mass spectrometry to identify SIK2-interacting ubiquitin ligases.
- Immunoprecipitation assays to confirm SIK2 and CUL4B-DDB1 interaction.
- Western blot analysis to assess CUL4B's role in SIK2 ubiquitination and degradation.
- Site-directed mutagenesis to identify critical SIK2 residues.
Main Results:
- SIC-19 promotes the interaction between SIK2 and the CUL4B-DDB1 E3 ubiquitin ligase complex.
- CUL4B is essential for SIC-19-induced SIK2 ubiquitination and subsequent degradation.
- SIK2 ubiquitination and half-life are dose-dependent on SIC-19 and CUL4B expression.
- Lysine 144 (K144) in SIK2 was identified as a critical residue for degradation, impacting cancer cell proliferation and migration.
Conclusions:
- SIC-19 induces SIK2 degradation via a novel CUL4B-dependent ubiquitination pathway.
- This mechanism highlights SIC-19's potential as a targeted therapeutic agent for cancers driven by SIK2.
- Targeting SIK2 degradation represents a promising strategy for ovarian cancer therapy.
Related Concept Videos
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...

